What do you need to know?
- Retinal dystrophy is an inherited eye disease leading to progressive degeneration of the photosensitive retina and decreased vision.
- Symptoms may include dusk blindness, tunnel vision, loss of acuity and colour vision disturbances.
- Diagnosis requires genetic and ophthalmic testing; support with gene therapies or retinal cell transplants is possible.
- The disease is not curable, but progression can be slowed down and quality of life improved with modern treatments and optical aids.
Retinal dystrophy is a group of inherited eye diseases that lead to progressive damage to the retina - the thin, light-sensitive layer located at the back of the eyeball. The retina is responsible for converting light into signals that the brain interprets as images. In cases of retinal dystrophy, the functioning of this structure deteriorates, causing vision problems and, in advanced cases, can lead to loss of vision.
Retinal dystrophy usually progresses slowly and the nature and course of the condition varies. A distinction is made between inter alia. zwyrodnienie barwnikowe siatkówki (retinitis pigmentosa), dystrofię czopkowo-pręcikową oraz młodzieńcze zwyrodnienie plamki żółtej. Wszystkie te schorzenia mają wspólną cechę – są wynikiem stopniowej degeneracji komórek siatkówki, takich jak fotoreceptory czy nabłonek barwnikowy siatkówki.
One of the key causes of retinal dystrophy is genetic mutations that disrupt the normal function of retinal cells. These diseases can be inherited in different ways, so genetic testing and genetic counselling are used in diagnosis to help patients and their families better understand the risk of passing the disease on to the next generation.1
What is retinal dystrophy?
Retinal dystrophy involves the progressive degeneration of retinal cells, such as photoreceptors and the retinal pigment epithelium, which are crucial for normal vision. As a result of this process, retinal function deteriorates, resulting in varying degrees of vision loss. Hereditary retinal dystrophy is the result of genetic mutations that affect the normal function of the retina, and its course depends on individual genetic susceptibility and the type of disease.
W zależności od typu dystrofii, choroba może objawiać się w różnym wieku. Niektóre przypadki, takie jak retinopatia barwnikowa, są diagnozowane już we wczesnym dzieciństwie, podczas gdy inne, jak młodzieńcze zwyrodnienie plamki żółtej, rozwijają się później. Postępująca degeneracja siatkówki może prowadzić do takich objawów jak widzenie tunelowe, problemy z widzeniem nocnym (ślepota zmierzchowa) oraz utrata pola widzenia.2
The diagnosis of retinal dystrophy includes genetic testing and clinical tests, such as clinical diagnosis and visual field assessment. Genetic counselling plays a key role in understanding the mechanisms of disease transmission and in family planning decisions. In some cases, the progression of the disease can be slowed down with modern therapies, including gene therapies, which are currently under intensive investigation.
Symptoms of hereditary retinal dystrophy
Hereditary retinal dystrophy manifests as a gradual deterioration of visual function, resulting from the gradual degeneration of retinal cells. The disease usually progresses slowly and symptoms vary depending on the type of dystrophy.
Most common symptoms:
- Twilight blindness - difficulty seeing in low light, typical of pigmentary retinopathy.
- Tunnel vision - progressive loss of peripheral visual field.
- Loss of visual acuity - especially when the central part of the retina is involved.
- Colour vision disorder - result from damage to the cones responsible for colour vision.
Symptoms can appear as early as childhood or in adulthood, depending on the type of disease and individual genetic predisposition.
Diagnostics and the importance of genetics
Genetic tests play a key role in identifying the type of retinal dystrophy and allow a more accurate determination of the course of the disease. They can also point to the possibility of modern gene therapies, which in some cases slow down the progression of the disease and improve the patient's quality of life.
Is dystrophy a degeneration?
Yes, retinal dystrophy is a type of degeneration that results from the progressive degeneration of the retina - the light-sensitive layer responsible for normal vision. These diseases include a group of hereditary conditions, such as pigmentary retinopathy, which develop as a result of genetic mutations. This process leads to progressive damage to retinal cells, including photoreceptors and bipolar cells, resulting in deteriorating vision.
Retinal dystrophy is a condition that is often characterised by a slow progression of the disease. The first symptoms, such as dusk blindness or loss of visual field, may appear as early as childhood or young adulthood, but the rate of progression of the disease depends on individual genetic predisposition.
Modern medicine offers various diagnostic options, such as genetic tests to identify the cause of the disease and assess the risk of inheritance. Modern therapies, including gene therapies, aim to slow the progression of the disease, although a complete cure for retinal dystrophy remains a challenge.
Can retinal degeneration be cured?
Currently, retinal dystrophy, including hereditary retinal dystrophy, is not completely curable, but medical advances offer hope for slowing the progression of the disease and improving patients' quality of life. These diseases, resulting from progressive degeneration of the retina, are part of a group of diseases with a variety of genetic causes, which means that treatment must be individually tailored.
Available treatments:
- Gene therapies - Modern gene therapies, developed especially in Western countries, aim to repair damaged genes or replace them with healthy versions. Some of these are already being used to treat inherited retinal diseases (IRDs).
- Supportive treatment - It includes the use of measures to improve visual function, such as specialised glasses, dietary supplements or vision-enhancing technologies.
- Retinal cell transplantation - Research into retinal cell transplants, such as photoreceptor cells, offers the possibility of rebuilding damaged retinal structure.
Despite the lack of a complete cure, appropriate management and access to modern therapies make it possible to significantly slow the progression of the disease and, in some cases, to save residual vision.
Ważne pytania i odpowiedzi
-
Early symptoms of retinal dystrophy may include difficulty seeing in low light, known as dusk blindness, and mild deterioration of the peripheral vision. Some people may also notice problems with the precision of their vision, especially in difficult lighting conditions.
-
Most retinal dystrophies have a genetic basis and are hereditary, but there are different mechanisms of transmission, including autosomal dominant, recessive and X-chromosome-coupled inheritance. In some cases, spontaneous genetic mutations may occur.
-
Retinal dystrophy usually progresses slowly, and the duration and severity of symptoms vary depending on the type of disease and individual genetic predisposition. In some individuals, the process can take decades, while in others it progresses more rapidly.
-
People with retinal dystrophy can benefit from a variety of optical aids, such as magnifiers, specialised glasses or digital devices to support vision. Space adaptations, such as better lighting, and psychological support can significantly improve quality of life.
-
Yes, there is currently a lot of research into modern therapies, including gene therapies to repair or replace damaged genes. In addition, retinal cell regeneration methods such as photoreceptor transplantation and stem cell-based therapies are being developed.
